ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, ...

In a series of operations across Delhi, Uttar Pradesh, and Himachal Pradesh, Delhi's Anti-Narcotics Task Force (ANTF) busted ...

Akums Drugs and Pharmaceuticals Ltd., India’s largest contract development and manufacturing organization (CDMO), has ...

Here are three reasons why there are better opportunities than ANIP and a stock we'd rather own. 1. Fewer Distribution ...

Sudeep Pharma Limited, a leading manufacturer of pharmaceutical and food-grade mineral ingredients, has announced the ...

The trial’s primary endpoint is the change in gout pain intensity from baseline in the target joint at day three.

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2025 Earnings Call Transcript May 9, 2025 ANI Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1.7, expectations were $1.37.

May 09, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the first quarter ended March 31 ...

ANI Pharmaceuticals has reported a strong first quarter for 2025, with earnings per share (EPS) of $1.70, significantly surpassing the forecasted EPS of $1.34. The company’s revenue reached $197 ...

ANI Pharmaceuticals (NASDAQ:ANIP) is gearing up to announce its quarterly earnings on Friday, 2025-05-09. Here's a quick overview of what investors should know before the release. Analysts are ...